Fig. 1: Categorical response rates to venetoclax. | Blood Cancer Journal

Fig. 1: Categorical response rates to venetoclax.

From: Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis

Fig. 1

A All patients and according to (B) number of prior treatments, C treatment on trial vs. not, and D prior treatment with BTKi vs. not. BTKi Bruton tyrosine kinase inhibitor, CR complete response, MR minor response, ORR overall response rate, PR partial response, VGPR very good partial response.

Back to article page